Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)

Clinical trial NCT07073365 · RECRUITING

Trial details

NCT number: NCT07073365
Sponsor: Pusan National University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Epidermal Growth Factor Receptor

Start date: 2025-07-01
Primary completion: 2030-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.